These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3349314)

  • 21. [The potential hormonal therapy of prostatic carcinoma].
    Studer UE; Altwein J; Bartsch G
    Urologe A; 1991 Sep; 30(5):310-6. PubMed ID: 1949440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study.
    Qureshi SA; Burch N; Druce M; Hattersley JG; Khan S; Gopalakrishnan K; Darby C; Wong JL; Davies L; Fletcher S; Shatwell W; Sothi S; Randeva HS; Dimitriadis GK; Weickert MO
    BMJ Open; 2016 May; 6(5):e010765. PubMed ID: 27147385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoma of the exocrine pancreas: a sex hormone responsive tumour?
    Greenway BA
    Br J Surg; 1987 Jun; 74(6):441-2. PubMed ID: 3607393
    [No Abstract]   [Full Text] [Related]  

  • 24. Adenocarcinoma of the pancreas--a hormone sensitive tumor? A preliminary report on Nolvadex treatment.
    Theve NO; Pousette A; Carlström K
    Clin Oncol; 1983 Sep; 9(3):193-7. PubMed ID: 6616993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Steroid hormones and pancreas: a new paradigm].
    Morales-Miranda A; Robles-Díaz G; Díaz-Sánchez V
    Rev Invest Clin; 2007; 59(2):124-9. PubMed ID: 17633800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of hormones and actinomycin on tumor cell multiplication in in vitro experiments].
    Spitsa AI; Arkhipenko VI
    Vopr Onkol; 1971; 17(4):80-4. PubMed ID: 4105159
    [No Abstract]   [Full Text] [Related]  

  • 27. A phase II study to evaluate tamoxifen in pancreatic adenocarcinoma.
    Crowson MC; Dorrell A; Rolfe EB; Fielding JW
    Eur J Surg Oncol; 1986 Dec; 12(4):335-6. PubMed ID: 3780986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel therapeutic approach for cancer using four cardiovascular hormones.
    Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
    Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International symposium on "Hormonal manipulation of cancer: peptides, growth factors and new (anti) steroidal agents." 4-6 June 1986, Rotterdam, The Netherlands. Abstracts.
    Eur J Cancer Clin Oncol; 1986 Jun; 22(6):711-51. PubMed ID: 3743607
    [No Abstract]   [Full Text] [Related]  

  • 30. [Surgical and hormonal treatment of breast carcinoma].
    SCHWAIGER M
    Dtsch Med Wochenschr; 1958 Apr; 83(14):540-4. PubMed ID: 13537688
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hormonal therapy; Its positive and negative aspects].
    Vasiukova EA; Margolis MG; Mal'kovich VK
    Klin Med (Mosk); 1978 Dec; 56(12):8-15. PubMed ID: 739753
    [No Abstract]   [Full Text] [Related]  

  • 32. Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
    Kuramoto M; Yamashita J; Ogawa M
    Cancer; 1995 Mar; 75(6):1263-72. PubMed ID: 7882277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second International Symposium on Hormonal Manipulation of Cancer: Peptides, Growth Factors and (Anti) Steroidal Agents. 9,10, and 11 April 1990, Rotterdam, The Netherlands. Abstracts.
    Eur J Cancer; 1990 Feb; 26(2):143-97. PubMed ID: 2138909
    [No Abstract]   [Full Text] [Related]  

  • 34. [Somatostatin analogs in the treatment of pancreatic cancer: utopia or feasible alternative?].
    Zalatnai A; Pogány V
    Orv Hetil; 2000 Oct; 141(43):2333-8. PubMed ID: 11089387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complementary hormonal treatment in carcinoma of the breast; 5 and 10-year results].
    SICARD A
    Presse Med (1893); 1957 Sep; 65(65):1455-7. PubMed ID: 13484828
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.
    Osei K; O'Dorisio TM
    Ann Intern Med; 1985 Aug; 103(2):223-5. PubMed ID: 2861769
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hormone dependent carcinomas and possibilities of hormonal therapy].
    Sprung M
    Vojnosanit Pregl; 1969 May; 26(5):248-50. PubMed ID: 5194622
    [No Abstract]   [Full Text] [Related]  

  • 38. Islet Cell Tumors of the Pancreas.
    Amin S; Kim MK
    Gastroenterol Clin North Am; 2016 Mar; 45(1):83-100. PubMed ID: 26895682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ten years of hormonal therapy of carcinoma of the prostate].
    HASCHEK H; SCHIMATZEK A
    Krebsarzt; 1955 Feb; 10(1):28-34. PubMed ID: 14392904
    [No Abstract]   [Full Text] [Related]  

  • 40. Somatostatin analogues and pancreatic acinar cell carcinoma: an alternative in symptomatic treatment?
    Feliu J; de la Gandara I; Garrido P; Gonzalez Baron M
    Am J Gastroenterol; 1990 Nov; 85(11):1539-40. PubMed ID: 1978552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.